AccuSafe guidewire versus needle for heart rhythm procedure
Part of Heart & circulation clinical trials.
This trial compares two different tools used during a minimally invasive heart procedure to treat atrial fibrillation (an irregular heartbeat). The study tests whether a newer guidewire tool is safer and works as well as the traditional needle approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 75 years old
- Diagnosed with atrial fibrillation and scheduled for catheter ablation (a procedure to correct irregular heartbeat)
- Normal heart septum anatomy confirmed by ultrasound before the procedure
- Willing to sign consent and complete follow-up visits as required
- No history of holes in the heart wall, heart valve surgery, or pacemaker implant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different catheters that use pulsed field energy to treat atrial fibrillation (a heart rhythm problem). It aims to find which one works better for people who need blood thinners but have a high risk of bleeding.
This trial compares two types of special catheters (thin tubes) used during a procedure called ablation to treat atrial fibrillation (irregular heartbeat). It aims to see which catheter works better during the procedure, and may help improve future treatments for people with heart rhythm problems.
This trial compares two types of specialized catheters used during heart rhythm ablation procedures to help doctors confirm they've created the right burn patterns. If you're having ablation for persistent atrial fibrillation or flutter with complex burn lines planned, this trial may help improve how your procedure is done.
This trial compares two minimally invasive heart procedures for persistent atrial fibrillation (a type of irregular heartbeat). The aim is to see which one is safer and more effective at restoring a normal heart rhythm.
This study compares a newer, faster type of ablation (high-power short-duration) with the standard approach for treating atrial fibrillation. The goal is to see which method is safer and more effective at restoring a normal heart rhythm.
This trial compares two different ways of delivering pulsed field ablation—a newer, targeted energy that zaps abnormal heart tissue—for people with atrial fibrillation. It aims to see if a single broader application works as well as a more focused, two-step approach, and it may help you feel better if you have symptoms from this irregular heartbeat.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.